Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study

The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may need to receive a second shot as the variant continues to spread across the US.